The global biopharma supply chain is on the brink of a significant shift, driven by legislative changes and economic pressures. The BIOSECURE Act and the Inflation Reduction Act (IRA) are poised to reshape the landscape and create new opportunities for India's Contract Development and Manufacturing
The increasing prevalence of foot-related pathologies, especially among the aging population, highlights the urgent need for advanced diagnostic tools in radiology and orthopedics. Addressing this necessity, Vienna-based ImageBiopsy Lab (IB Lab) has introduced IB Lab FROG, an innovative AI-powered
The global C-arms market is on the cusp of significant transformation, driven by technological advancements and evolving healthcare needs. Valued at $2.21 billion in 2023, the market is projected to reach $2.35 billion in 2024, continuing its growth trajectory. This article delves into the key
The global cell culture vessels market is on a remarkable growth trajectory, projected to expand from an estimated USD 4.90 billion in 2023 to over USD 19.65 billion by 2033. This significant growth, at a robust CAGR of 14.9% from 2024 to 2033, underscores the critical role of cell culture
The third quarter of 2024 has been a pivotal period for several digital health companies, showcasing their financial resilience and strategic advancements. This article delves into the financial performance and strategic maneuvers of WELL Health Technologies, DarioHealth, Clover Health, and
The pharmaceutical industry is no stranger to challenges and setbacks, especially in the area of neurological and psychiatric treatments. AbbVie, a multinational biopharmaceutical company, recently faced a significant hurdle when its promising schizophrenia drug, emraclidine, failed to meet
